Follow The Filings

ARI

Earnings company data as of 5:01 PM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 29 Oct EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by ARI's executives, directors and 10% owners in the last 12 months, from their Form 4s

All ARI insider trades
  • None no insider bought on the open market
  • $57K sold by 2 insiders outside a trading plan
  • $529K sold by 1 insider under 10b5-1 plans
  1. Michael Salvati Director
    Sale
    $6,586 960 shares at $6.86
    Traded Aug 25 Filed Aug 27
  2. Carmencita N.m. Whonder Director
    Sale
    $50K 4,574 shares at $10.93 16% of stake
    Traded May 13 Filed May 15
  3. Stuart Rothstein CEO
    Planned sale
    $529K 52,072 shares at $10.16 19% of stake
    Traded Dec 15, 2025 Filed Dec 16, 2025

Also filed in the last 12 months, not counted as buying or selling: 9 stock grants and 2 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 3.01,7.01,9.01
8-K 1.01,5.07
8-K 8.01
8-K 2.02,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G —
8-K 5.07
SCHEDULE 13G/A —
8-K 8.01,9.01
DEFA14A
DEF 14A
DEFA14A
8-K 5.02
10-K/A
SCHEDULE 13G —
8-K 2.02,9.01
SCHEDULE 13G —
10-Q
8-K 1.01,1.02,2.01,7.01,9.01
8-K 5.07
SCHEDULE 13G/A —
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.